Peter Greenleaf
Director; Director, Chief Executive Officer · 6 filings · Latest: Oct 2, 2026
Aurinia Pharmaceuticals Inc.
Pelthos Therapeutics Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
PTHS | Peter Greenleaf | Director | Oct 2, 2026 | Sale | $21.17 | 797 | $16.9K | 23,087 | |
PTHS | Peter Greenleaf | Director | Jul 2, 2026 | Sale | $26.13 | 797 | $20.8K | 23,884 | |
AUPH | PETER GREENLEAF | — | May 11, 2026 | Proposed Sale | $15.84 | 3,136,201 | $49.7M | — | |
PTHS | Peter Greenleaf | Director | Apr 2, 2026 | Sale | $20.92 | 797 | $16.7K | 24,681 |